Literature DB >> 22103619

Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes.

Jang-Won Son1, Eun-Hee Jang, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kun-Ho Yoon, Bong-Yun Cha, Ho-Young Son, Kwang-Woo Lee, Hanjoong Jo, Hyuk-Sang Kwon.   

Abstract

AIM: The aim of this study was to evaluate the association between the circulating BMP-4 levels and atherosclerosis in patients with Type 2 diabetes. MATERIAL &
METHODS: Serum BMP-4 levels were measured in 174 diabetic patients, and the degree of atherosclerosis was assessed by measuring the carotid intima-media thickness and the cardio-ankle vascular index.
RESULTS: Serum BMP-4 levels were inversely correlated with systolic blood pressure, triglycerides, free fatty acids, cardio-ankle vascular index and carotid intima-media thickness. Lower BMP-4 levels were shown to be an independent predictor of the increased cardio-ankle vascular index and carotid intima-media thickness after adjusting for conventional cardiovascular risk factors in patients with Type 2 diabetes.
CONCLUSION: Serum BMP-4 levels are inversely associated with surrogate markers of arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103619     DOI: 10.2217/bmm.11.81

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  8 in total

Review 1.  Role of lipotoxicity in endothelial dysfunction.

Authors:  Jeong-a Kim; Monica Montagnani; Sruti Chandrasekran; Michael J Quon
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

2.  Enhanced serum levels of matrix Gla protein and bone morphogenetic protein in acute coronary syndrome patients.

Authors:  Zafer Buyukterzi; Ummugulsum Can; Sertac Alpaydin; Asuman Guzelant; Sukru Karaarslan; Mehmet Mustu; Duygu Kocyigit; Kadri Murat Gurses
Journal:  J Clin Lab Anal       Date:  2017-06-12       Impact factor: 2.352

3.  Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Authors:  Carlos Ernesto Fernández-García; Stephania C Isaza; Esther Rey; Patricia Marañón; Rocío Gallego-Durán; Rocío Montero-Vallejo; Javier Rodríguez de Cía; Javier Ampuero; Manuel Romero-Gómez; Carmelo García-Monzón; Águeda González-Rodríguez
Journal:  Biomark Res       Date:  2022-05-25

Review 4.  Targeting BMP signalling in cardiovascular disease and anaemia.

Authors:  Nicholas W Morrell; Donald B Bloch; Peter ten Dijke; Marie-Jose T H Goumans; Akiko Hata; Jim Smith; Paul B Yu; Kenneth D Bloch
Journal:  Nat Rev Cardiol       Date:  2015-10-13       Impact factor: 32.419

5.  Changes in serum levels of bone morphogenic protein 4 and inflammatory cytokines after bariatric surgery in severely obese korean patients with type 2 diabetes.

Authors:  Mee Kyoung Kim; Eun-Hee Jang; Oak-Kee Hong; Hyun-Ji Chun; Soon-Jib Yoo; Ki-Hyun Baek; Wook Kim; Eung Kook Kim; Ki-Ho Song; Hyuk-Sang Kwon
Journal:  Int J Endocrinol       Date:  2013-09-19       Impact factor: 3.257

6.  Serum Bone Morphogenic Protein-4 Contributes to Discriminating Coronary Artery Disease Severity.

Authors:  Chul Soo Park; Oak-Kee Hong; Mee Kyoung Kim; Woo Baek Chung; Yun Seok Choi; Ki-Hyun Baek; Ki-Ho Song; Man Young Lee; Hyuk-Sang Kwon
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

7.  High glucose and palmitate increases bone morphogenic protein 4 expression in human endothelial cells.

Authors:  Oak-Kee Hong; Soon-Jib Yoo; Jang-Won Son; Mee-Kyoung Kim; Ki-Hyun Baek; Ki-Ho Song; Bong-Yun Cha; Hanjoong Jo; Hyuk-Sang Kwon
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

8.  Muscle-derived Dpp regulates feeding initiation via endocrine modulation of brain dopamine biosynthesis.

Authors:  Maricela Robles-Murguia; Deepti Rao; David Finkelstein; Beisi Xu; Yiping Fan; Fabio Demontis
Journal:  Genes Dev       Date:  2019-12-12       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.